共 157 条
[21]
Worku A(2014)Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Eur Respir J 44 P1519-1333
[22]
Walker V(2013)Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis Med J Aust 199 121-857
[23]
Goncharova EA(2014)Chronic sirolimus therapy for lymphangioleiomyomatosis Am J Respir Crit Care Med 190 1332-15
[24]
Goncharov DA(2004)An epidemiological study of renal pathology in tuberous sclerosis complex BJU Int 94 853-198
[25]
Li H(2005)Nephrotoxicity of rapamycin: an emerging problem in clinical medicine Nephrol Dial Transplant 20 13-805
[26]
Pimtong W(2011)Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis? Respir Res 12 66-180
[27]
Lu S(2004)Effect of sirolimus on infection incidence in liver transplant recipients Liver Transpl 10 193-undefined
[28]
Khavin I(2017)Sirolimus alters lung pathology and viral load following influenza a virus infection Respir Res 18 136-undefined
[29]
Bissler JJ(2011)Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus Ann Intern Med 154 797-undefined
[30]
McCormack FX(2015)Severity and outcome of cystic lung disease in women with tuberous sclerosis complex Eur Respir J 45 171-undefined